Ask
Search
My library
ORKG

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.41.0
Backend: v1.13.4

We use cookies to provide a better user experience.

Data Protection

Breakdown of the type of analogue insulin prescribed during each of the time periods in each region.

Rachel A. Charlton (399538)
Kari Klungsøyr (2549296)
Amanda J. Neville (3169185)
Sue Jordan (432125)
Anna Pierini (3169173)
Lolkje T. W. de Jong-van den Berg (3169188)
H. Jens Bos (3169197)
Aurora Puccini (3169176)
Anders Engeland (276146)
Rosa Gini (451348)
Gareth Davies (679965)
Daniel Thayer (3169194)
Anne V. Hansen (3169179)
Margery Morgan (3169170)
Hao Wang (39217)
Anita McGrogan (113903)
Anne-Marie Nybo Andersen (298403)
Helen Dolk (3169182)
Ester Garne (3169191)

Publication date

May 2016

DOI

10.1371/journal.pone.0155737.g004

Abstract

<p>Breakdown of the type of analogue insulin prescribed during each of the time periods in each region.</p

Extracted data

Related items

Study population characteristics at index date (when basal insulin was initiated).

Jo Satoh (5758994)
Marc Andersen (585534)
Brian Bekker Hansen (5165108)
Brian Larsen Thorsted (4925449)
Deniz Tutkunkardas (4918735)
Mette Zacho (5758997)
Hiroshi Maegawa (103055)

September 2018

Study population characteristics at index date (when basal insulin was initiated).</p

Diabetic duration of all antihyperglycermic drugs use.

Yi-Sheng Liou (527831)
Fu-Yu Yang (5702678)
Hung-Yi Chen (316493)
Gwo-Ping Jong (5171768)

August 2018

The diabetic duration for users of insulin was significant longer than that for non-users (p (DOCX)...

Depicted above are: (a) glucose time series for different values of the constant affecting insulin secretion, ; (b) glucose time series density for different values of the constant affecting insulin secretion, .

D. J. Albers (293830)
Noémie Elhadad (522968)
E. Tabak (578532)
A. Perotte (578533)
George Hripcsak (242191)

June 2014

<p>Depicted above are: (a) glucose time series for different values of the constant affecting insuli...

A practical guide to the interpretation of PK/PD profiles of longer-acting analogue insulins. Part two: Insulin degludec vs. insulin glargine U300

Greeff, Oppel B.W.
van Tonder, Jacob John
Naidu, Kershlin
McMaster, Alicia
van Tonder, Alet
Mothilal, Rashem

August 2018

Glucose clamp studies form an integral part of the early development of insulin therapies. Data gene...

The distribution of medications in NPH and premixed insulin-initiated T2DM patients.

Ashenafi Kibret Sendekie (12646960)
Adeladlew Kassie Netere (4621486)
Eyayaw Ashete Belachew (13840796)

September 2022

The distribution of medications in NPH and premixed insulin-initiated T2DM patients.</p

Distribution of surrogate measures for insulin resistance at baseline examination.

Bongyoung Kim (4500778)
Hyun Young Choi (5954465)
Wonhee Kim (5489063)
Chiwon Ahn (3900493)
Juncheol Lee (3900487)
Jae Guk Kim (5954468)
Jihoon Kim (10090)
Hyungoo Shin (3900496)
Jae Myung Yu (4471231)
Shinje Moon (3715765)

November 2018

Distribution of surrogate measures for insulin resistance at baseline examination.</p

Comparison of blood glucose levels between NPH and premixed insulin regimens.

Ashenafi Kibret Sendekie (12646960)
Adeladlew Kassie Netere (4621486)
Eyayaw Ashete Belachew (13840796)

September 2022

Comparison of blood glucose levels between NPH and premixed insulin regimens.</p

Summary of measures and dispersion on consultation and consumption of antihypertensive drugs for the three periods of analysis of the results.

Maurílio de Souza Cazarim (2838158)
Osvaldo de Freitas (2838161)
Thais Rodrigues Penaforte (2838164)
Angela Achcar (2838167)
Leonardo Régis Leira Pereira (492901)

June 2016

<p>Summary of measures and dispersion on consultation and consumption of antihypertensive drugs for ...

A practical guide to the interpretation of PK/PD profiles of longer-acting analogue insulins. Part two : insulin degludec vs. insulin glargine U300

Greeff, Oppel Bernhardt Wilhelm
Van Tonder, Jacob John
Naidu, Kershlin
McMaster, Alicia
Van Tonder, Alet
Mothilal, Rashem

January 2018

Glucose clamp studies form an integral part of the early development of insulin therapies. Data gene...

Summary of medication undertaken by each patient in each diagnostic group.

Dorit Ben-Shachar (78688)
Rachel Karry (78689)

February 2013

<p>Summary of medication undertaken by each patient in each diagnostic group.</p

Comparison of clinical studies of insulin plus glucose for the treatment of hyperkalemia.

Armando Coca (3801550)
Ana Lucia Valencia (3801556)
Jesus Bustamante (3801553)
Alicia Mendiluce (3801547)
Jürgen Floege (13260)

February 2017

<p>Comparison of clinical studies of insulin plus glucose for the treatment of hyperkalemia.</p

Descriptive statistics for the average insulin administration dose and plasma insulin and glucose levels in open- and closed-loop (N = 14).

Ulrike Schierloh (6039686)
Malgorzata E. Wilinska (6440261)
Ineke M. Pit-ten Cate (6440264)
Petra Baumann (6440267)
Roman Hovorka (5825945)
Carine De Beaufort (6440270)

March 2019

Descriptive statistics for the average insulin administration dose and plasma insulin and glucose le...

Comparison of vascular and metabolic parameters between the control and treated groups at each time point and comparison of each parameter between time points in each group.

Su Yeon Ahn (753404)
Jin Mo Goo (507438)
Kyung Hee Lee (753401)
Seunggyun Ha (691221)
Jin Chul Paeng (621230)

February 2018

<p>Comparison of vascular and metabolic parameters between the control and treated groups at each ti...

The rate of hypoglycemia and glycemic control between NPH and premixed insulin regimens.

Ashenafi Kibret Sendekie (12646960)
Adeladlew Kassie Netere (4621486)
Eyayaw Ashete Belachew (13840796)

September 2022

The rate of hypoglycemia and glycemic control between NPH and premixed insulin regimens.</p

Breakdown of prescribed CVD medications in the Kenyatta National Hospital cohort.

David Wata (4739265)
John Ogwu (5620937)
Louise Dunford (14485522)
Graham Lawson (5620934)
Sangeeta Tanna (5620940)

January 2023

Breakdown of prescribed CVD medications in the Kenyatta National Hospital cohort.</p

Study population characteristics at index date (when basal insulin was initiated).

Jo Satoh (5758994)
Marc Andersen (585534)
Brian Bekker Hansen (5165108)
Brian Larsen Thorsted (4925449)
Deniz Tutkunkardas (4918735)
Mette Zacho (5758997)
Hiroshi Maegawa (103055)

September 2018

Study population characteristics at index date (when basal insulin was initiated).</p

Diabetic duration of all antihyperglycermic drugs use.

Yi-Sheng Liou (527831)
Fu-Yu Yang (5702678)
Hung-Yi Chen (316493)
Gwo-Ping Jong (5171768)

August 2018

The diabetic duration for users of insulin was significant longer than that for non-users (p (DOCX)...

Depicted above are: (a) glucose time series for different values of the constant affecting insulin secretion, ; (b) glucose time series density for different values of the constant affecting insulin secretion, .

D. J. Albers (293830)
Noémie Elhadad (522968)
E. Tabak (578532)
A. Perotte (578533)
George Hripcsak (242191)

June 2014

<p>Depicted above are: (a) glucose time series for different values of the constant affecting insuli...

A practical guide to the interpretation of PK/PD profiles of longer-acting analogue insulins. Part two: Insulin degludec vs. insulin glargine U300

Greeff, Oppel B.W.
van Tonder, Jacob John
Naidu, Kershlin
McMaster, Alicia
van Tonder, Alet
Mothilal, Rashem

August 2018

Glucose clamp studies form an integral part of the early development of insulin therapies. Data gene...

The distribution of medications in NPH and premixed insulin-initiated T2DM patients.

Ashenafi Kibret Sendekie (12646960)
Adeladlew Kassie Netere (4621486)
Eyayaw Ashete Belachew (13840796)

September 2022

The distribution of medications in NPH and premixed insulin-initiated T2DM patients.</p

Distribution of surrogate measures for insulin resistance at baseline examination.

Bongyoung Kim (4500778)
Hyun Young Choi (5954465)
Wonhee Kim (5489063)
Chiwon Ahn (3900493)
Juncheol Lee (3900487)
Jae Guk Kim (5954468)
Jihoon Kim (10090)
Hyungoo Shin (3900496)
Jae Myung Yu (4471231)
Shinje Moon (3715765)

November 2018

Distribution of surrogate measures for insulin resistance at baseline examination.</p

Comparison of blood glucose levels between NPH and premixed insulin regimens.

Ashenafi Kibret Sendekie (12646960)
Adeladlew Kassie Netere (4621486)
Eyayaw Ashete Belachew (13840796)

September 2022

Comparison of blood glucose levels between NPH and premixed insulin regimens.</p

Summary of measures and dispersion on consultation and consumption of antihypertensive drugs for the three periods of analysis of the results.

Maurílio de Souza Cazarim (2838158)
Osvaldo de Freitas (2838161)
Thais Rodrigues Penaforte (2838164)
Angela Achcar (2838167)
Leonardo Régis Leira Pereira (492901)

June 2016

<p>Summary of measures and dispersion on consultation and consumption of antihypertensive drugs for ...

A practical guide to the interpretation of PK/PD profiles of longer-acting analogue insulins. Part two : insulin degludec vs. insulin glargine U300

Greeff, Oppel Bernhardt Wilhelm
Van Tonder, Jacob John
Naidu, Kershlin
McMaster, Alicia
Van Tonder, Alet
Mothilal, Rashem

January 2018

Glucose clamp studies form an integral part of the early development of insulin therapies. Data gene...

Summary of medication undertaken by each patient in each diagnostic group.

Dorit Ben-Shachar (78688)
Rachel Karry (78689)

February 2013

<p>Summary of medication undertaken by each patient in each diagnostic group.</p

Comparison of clinical studies of insulin plus glucose for the treatment of hyperkalemia.

Armando Coca (3801550)
Ana Lucia Valencia (3801556)
Jesus Bustamante (3801553)
Alicia Mendiluce (3801547)
Jürgen Floege (13260)

February 2017

<p>Comparison of clinical studies of insulin plus glucose for the treatment of hyperkalemia.</p

Descriptive statistics for the average insulin administration dose and plasma insulin and glucose levels in open- and closed-loop (N = 14).

Ulrike Schierloh (6039686)
Malgorzata E. Wilinska (6440261)
Ineke M. Pit-ten Cate (6440264)
Petra Baumann (6440267)
Roman Hovorka (5825945)
Carine De Beaufort (6440270)

March 2019

Descriptive statistics for the average insulin administration dose and plasma insulin and glucose le...

Comparison of vascular and metabolic parameters between the control and treated groups at each time point and comparison of each parameter between time points in each group.

Su Yeon Ahn (753404)
Jin Mo Goo (507438)
Kyung Hee Lee (753401)
Seunggyun Ha (691221)
Jin Chul Paeng (621230)

February 2018

<p>Comparison of vascular and metabolic parameters between the control and treated groups at each ti...

The rate of hypoglycemia and glycemic control between NPH and premixed insulin regimens.

Ashenafi Kibret Sendekie (12646960)
Adeladlew Kassie Netere (4621486)
Eyayaw Ashete Belachew (13840796)

September 2022

The rate of hypoglycemia and glycemic control between NPH and premixed insulin regimens.</p

Breakdown of prescribed CVD medications in the Kenyatta National Hospital cohort.

David Wata (4739265)
John Ogwu (5620937)
Louise Dunford (14485522)
Graham Lawson (5620934)
Sangeeta Tanna (5620940)

January 2023

Breakdown of prescribed CVD medications in the Kenyatta National Hospital cohort.</p

Study population characteristics at index date (when basal insulin was initiated).

Jo Satoh (5758994)
Marc Andersen (585534)
Brian Bekker Hansen (5165108)
Brian Larsen Thorsted (4925449)
Deniz Tutkunkardas (4918735)
Mette Zacho (5758997)
Hiroshi Maegawa (103055)

September 2018

Study population characteristics at index date (when basal insulin was initiated).</p

Diabetic duration of all antihyperglycermic drugs use.

Yi-Sheng Liou (527831)
Fu-Yu Yang (5702678)
Hung-Yi Chen (316493)
Gwo-Ping Jong (5171768)

August 2018

The diabetic duration for users of insulin was significant longer than that for non-users (p (DOCX)...

Depicted above are: (a) glucose time series for different values of the constant affecting insulin secretion, ; (b) glucose time series density for different values of the constant affecting insulin secretion, .

D. J. Albers (293830)
Noémie Elhadad (522968)
E. Tabak (578532)
A. Perotte (578533)
George Hripcsak (242191)

June 2014

<p>Depicted above are: (a) glucose time series for different values of the constant affecting insuli...